Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison Between Tailored Therapy Guided by a Non-invasive Antibiotic Susceptibility Test and Empiric Treatment for First-line Helicobacter Pylori Eradication in Patients With Dyspepsia: a Randomized Controlled Trial.

NCT04107194 is registered in ClinicalTrials.gov with University of Bari as lead sponsor.

NCT NCT04107194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04107194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison Between Tailored Therapy Guided by a Non-invasive Antibiotic Susceptibility Test and Empiric Treatment for First-line Helicobacter Pylori Eradication in Patients With Dyspepsia: a Randomized Controlled Trial.
Lead sponsor
University of Bari
Phase
Phase 3
Overall status
Unknown status
Start date
January 14, 2020
Completion date
April 14, 2022
Enrollment
362 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic resistant infection, antibiotic resistant strain, helicobacter pylori infection